Identify the business objective
State whether the project concerns CMO, CDMO, technology transfer, product and registration cooperation, or another defined opportunity.
Global pharmaceutical partnership workspace
Move from a public question
to a controlled project decision.
Use this workspace to check public capability scope, prepare a non-confidential project brief, understand the NDA pathway and request a preliminary assessment.
Begin with facts that can be safely shared
A useful first conversation does not need formulas, dossiers, patient information or trade secrets. It needs enough context to decide whether a focused assessment is responsible.
Describe the project at a high level
Provide the dosage form, target market, project stage, presentation, indicative timing and a short non-confidential objective.
Check the public platform scope
Review the confirmed dosage-form platforms and the limits of public information before assuming product or capacity fit.
Choose the confidentiality gate
Use the initial form for non-confidential facts. Exchange technical packages only after a mutual NDA and agreed request list.
Self-qualification
Project readiness self-check
Before submitting an inquiry, a prospective partner should be able to answer most of these questions without exposing confidential information.
- Which legal entity is making the inquiry and what role will it hold in the target market?
- Which dosage form, presentation and high-level product route are relevant?
- Which market or markets are being considered?
- Is the project at early evaluation, development, scale-up, registration, commercial supply or transfer planning?
- Which cooperation model is being explored: CMO, CDMO, technology transfer, product and registration cooperation, or another path?
- What decision, milestone or timing window makes an initial assessment useful now?
Decision resources
Use the right decision resource
Public capability and evidence
Review Hainan Hailing's public facts, dosage-form platforms and careful regulatory wording.
Open public facts →Project evaluation pathway
See how an initial screen moves through NDA, diligence, transfer and commercial readiness.
Open project pathway →Quality and regulatory partnership
Understand how quality responsibilities, evidence and communications should be controlled.
Open quality resource →Technical due diligence guides
Read the practical CMO/CDMO, sterile-manufacturing and technology-transfer guides.
Open insight library →After submission
What happens after a preliminary assessment request
Acknowledgement
A valid business inquiry is normally acknowledged within three business days. This is not project acceptance or a quotation.
Clarification
The first response may ask for a clearer non-confidential description of the market, dosage form, stage, timing or intended cooperation model.
Mutual NDA
Where there is a plausible project fit, the parties can agree a confidentiality route before technical or commercial materials are exchanged.
Controlled diligence
Technical, quality, regulatory, supply and commercial evidence can then be reviewed against an agreed request list, access scope and decision plan.
CMO · CDMO · Technology Transfer
Start with a focused, non-confidential project brief.
The secure inquiry form captures the minimum information needed to assess project fit. It is not a quotation, product commitment or regulatory opinion.